Kavya Deshpande

Stock Analyst at UBS

(1.13)
# 3,603
Out of 4,417 analysts
47
Total ratings
58.3%
Success rate
-2.6%
Average return

Stocks Rated by Kavya Deshpande

bioMérieux S.A.
Jun 1, 2026
Downgraded: Hold
Price Target: €138.00€80.00
Current: $68.10
Upside: +17.47%
Demant A/S
May 21, 2026
Reiterated: Buy
Price Target: $42
Current: $35.45
Upside: +19.51%
DiaSorin S.p.A.
Apr 9, 2026
Downgraded: Hold
Price Target: €84.00€66.00
Current: $66.44
Upside: -0.66%
Vimian Group AB (publ)
Feb 17, 2026
Maintained: Hold
Price Target: kr 34.00kr 30.00
Current: $31.60
Upside: -5.06%
Elekta AB (publ)
Sep 3, 2025
Initiated Coverage: Sell
Price Target: kr 34.00
Current: $51.60
Upside: -34.11%